Regulus Therapeutics
Utility Patent Applications

Last updated:

List of all Regulus Therapeutics patents 13 in total

Status Patent
Application
Utility: METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE External link
Filling date: 6 Sep 2025 Issue date: 7 Jul 2022
Application
Utility: MicroRNA Compounds and Methods for Modulating MIR-10B Activity External link
Filling date: 6 Sep 2025 Issue date: 31 Mar 2022
Application
Utility: Methods for Oral Delivery of Oligonucleotides External link
Filling date: 6 Sep 2025 Issue date: 31 Mar 2022
Application
Utility: METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE External link
Filling date: 6 Sep 2025 Issue date: 27 Jan 2022
Application
Utility: Galnac Conjugated Modified Oligonucleotides as MIR-122 Inhibitor Having HCV Antiviral Activity with Reduced Hyperbilirubinemia Side-Effect External link
Filling date: 6 Sep 2025 Issue date: 10 Jun 2021
Application
Utility: MicroRNA Compounds and Methods for Modulating MIR-122 External link
Filling date: 6 Sep 2025 Issue date: 15 Apr 2021
Application
Utility: Modified Oligonucleotides for Treatment of Polycystic Kidney Disease External link
Filling date: 6 Sep 2025 Issue date: 1 Apr 2021
Application
Utility: METHODS AND COMPOSITIONS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE External link
Filling date: 6 Sep 2025 Issue date: 17 Dec 2020
Application
Utility: METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE External link
Filling date: 6 Sep 2025 Issue date: 17 Dec 2020
Application
Utility: METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE External link
Filling date: 6 Sep 2025 Issue date: 23 Jul 2020
Application
Utility: Modified Oligonucleotides for Treatment of Polycystic Kidney Disease External link
Filling date: 6 Sep 2025 Issue date: 28 May 2020
Application
Utility: METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE External link
Filling date: 6 Sep 2025 Issue date: 14 Nov 2019
Application
Utility: Compounds and Methods for Enhanced Cellular Uptake External link
Filling date: 6 Sep 2025 Issue date: 10 Oct 2019

Showing 1 to 13 of 13 patents.